Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer's disease (AD), related dementias and cognitive aging. The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising drug discovery and development programs. In addition to funding academic programs, the ADDF also invests in and creates early stage biotechnology companies. The ADDF also co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation. |
Característiques principals
Priority areas for this RFP: For the purposes of this RFP, repurposed drugs includes both drugs that have been approved for other indications as well as compounds still under development for other conditions (sometimes referred to as ‘repositioning’). Proposals should be hypothesis driven and drug(s) chosen for testing should target a mechanism of action(s) with strong rationale for dementia. Interdisciplinary teams are highly encouraged. |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
Convocatòria (URL)
Convocatòria: http://www.alzdiscovery.org/assets/content/static/2014_Repurposing_RFP_FINAL.pdf http://www.alzdiscovery.org/research-and-grants/applyforfunding |
Dotació
$100,000 to $ 1,500,000, depending on the stage of the research project. |
AVÍS IMPORTANT
Deadline: June 5. A Letter of Intent should be submitted two weeks before the deadline. Interested applicants must first submit a Letter of Intent electronically via the ADDF website. |
Arxius
Arxiu |
---|
Request for Proposals |